Matinas Biopharma Holdings Inc. Company Profile
NYSE: MTNBHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Matinas Biopharma at a glance
Matinas Biopharma Holdings Inc. (NYSE: MTNB) is a Biotechnology company in the Healthcare sector headquartered in Bedminster, NJ. Matinas Biopharma is led by Mr. Jerome D. Jabbour J.D. and employs about 2 people. The company's shares have traded publicly since 2017.
At a market capitalization of $2.8 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001582554, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Matinas Biopharma do?
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Matinas Biopharma Holdings Inc.
- Ticker
- NYSE: MTNB
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jerome D. Jabbour J.D.
- Employees
- 2
- Headquarters
- 1545 Route 206 South, Bedminster, NJ, United States
- Phone
- 908 484 8805
- Website
- matinasbiopharma.com
- IPO year
- 2017
- Market cap
- $2.77M
- SEC CIK
- 0001582554
Companies similar to Matinas Biopharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VRAXVirax Biolabs Group Limited | 1.99 | -5.69% | $2.68M | vs MTNB |
| GOVXGeoVax Labs Inc. | 0.2866 | -0.97% | $2.90M | vs MTNB |
| BRTXBioRestorative Therapies Inc. | 1.89 | -15.63% | $2.61M | vs MTNB |
| VIVSVivoSim Labs Inc. | 0.1772 | -7.47% | $2.94M | vs MTNB |
| SPRCSciSparc Ltd. | 4.43 | -4.53% | $2.57M | vs MTNB |
| SILOSilo Pharma Inc. | 1.45 | +0.69% | $2.98M | vs MTNB |
| ELABPMGC Holdings Inc. | 3.13 | -2.04% | $2.53M | vs MTNB |
| MLECMoolec Science SA | 4.19 | -12.89% | $3.04M | vs MTNB |